Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease

scientific article

Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2010/383281
P932PMC publication ID3065810
P698PubMed publication ID21490915
P5875ResearchGate publication ID51049283

P50authorMilagros C RosalQ85855135
Judith K. OckeneQ113389547
Ira S. OckeneQ113390764
Philip A MerriamQ114515555
Yunsheng MaQ47257728
P2093author name stringPritesh J Gandhi
P2860cites workLow rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.Q51611276
Smoking cessation and severity of disease: the Coronary Artery Smoking Intervention StudyQ68120262
Facilitating dietary change: the patient-centered counseling modelQ73674394
Long-term persistence in use of statin therapy in elderly patientsQ74497691
Persistence of use of lipid-lowering medications: a cross-national studyQ74586986
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)Q27860959
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportQ27861020
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialQ28214393
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigatorsQ29547887
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesQ29619614
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsQ29620696
Provider training for patient-centered alcohol counseling in a primary care settingQ30233795
Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec dataQ31048045
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery diseaseQ33611567
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeQ34595917
Dietary quality 1 year after diagnosis of coronary heart diseaseQ36662790
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.Q37224119
Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trialQ38402228
Apparent discontinuation rates in patients prescribed lipid-lowering drugs.Q39420320
Pharmacists' ability to influence outcomes of hypertension therapyQ39439695
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?Q40496473
Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) InvestQ40778873
Medication compliance: a healthcare problemQ40859935
When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk ReductionQ40900446
The assessment of refill compliance using pharmacy records: methods, validity, and applicationsQ41361915
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.Q45142621
Physician-pharmacist comanagement of hypertension: a randomized, comparative trialQ46151910
Severity of angiographically proven coronary artery disease predicts smoking cessationQ48871925
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P921main subjectheart diseaseQ190805
coronary artery diseaseQ844935
P304page(s)383281
P577publication date2010-08-17
P1433published inCholesterolQ26842087
P1476titleRandomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease
P478volume2010

Reverse relations

cites work (P2860)
Q28080044A Metaanalysis of Interventions to Improve Adherence to Lipid-Lowering Medication
Q35788550A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway - a randomized controlled trial.
Q38232840Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review.
Q93184705Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States
Q54561788Does hospitalization influence patients' medication adherence and community pharmacists' interventions?
Q35965141Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease
Q92480262Impact of pharmacy care upon adherence to cardiovascular medicines: a feasibility pilot controlled trial
Q34547763Interventions to improve adherence to lipid-lowering medication.
Q38774887Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials.
Q28066001Patient-Centered Interventions to Improve Adherence to Statins: A Narrative Synthesis of Systematically Identified Studies
Q33568055The effect of telephone support interventions on coronary artery disease (CAD) patient outcomes during cardiac rehabilitation: a systematic review and meta-analysis

Search more.